首页 > 最新文献

Journal of Thoracic and Cardiovascular Surgery最新文献

英文 中文
Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non−small cell lung cancer 与叶下切除术相比,肺叶切除术可提高高风险IA期非小细胞肺癌的无病生存率。
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/j.jtcvs.2025.08.024
Raul Caso MD, MSCI , Nanruoyi Zhou MD , Matthew Skovgard MD , Nicolas Toumbacaris MSPH , Kay See Tan PhD , Prasad S. Adusumilli MD , Manjit S. Bains MD , Matthew J. Bott MD , Robert J. Downey MD , James Huang MD , James M. Isbell MD, MSCI , Daniela Molena MD , Bernard J. Park MD , Gaetano Rocco MD , Valerie W. Rusch MD , Smita Sihag MD , David R. Jones MD , Katherine D. Gray MD

Objective

To investigate disease-free survival (DFS) of sublobar resection versus lobectomy for stage IA non−small cell lung cancer (NSCLC) with preoperative high-risk features.

Methods

Data were abstracted from a prospective database to identify patients with clinical T1a-T1bN0M0 NSCLC (≤2 cm) who underwent lobectomy or sublobar resection (wedge resection or segmentectomy). 1:1 propensity matching was used to balance the dataset for forced expiratory volume in 1 second ≥60% and high-risk features: cT1b versus cT1a, standard uptake value of the primary tumor on positron emission tomography, solid versus subsolid tumor texture on computed tomography, and micropapillary/solid histology. The primary outcome was DFS.

Results

In total, 825 patients met inclusion criteria: 52% (n = 426) patients underwent lobectomy and 48% (n = 399) of patients underwent sublobar resection (45% segmentectomy, 55% wedge resection). Lobectomy was associated with more preoperative high-risk features: cT1b (P < .001), greater standard uptake value (P < .001), solid tumor texture on computed tomography (P < .001), and micropapillary/solid histology (P < .001). In total, 660 patients were included in the matched analysis with all high-risk features balanced. Nodal upstaging (N1) was greater in patients who underwent lobectomy (9.1% vs 3.4%, P = .004). Five-year DFS (85% vs 74%, P = .12) was equivalent in the matched cohort. Lobectomy was protective for recurrence in the presence of 2 or greater high-risk features: sublobar resection patients with 2 high-risk features (hazard ratio, 1.77; 95% confidence interval, 1.13-2.76, P = .012) or 3-4 high-risk features (hazard ratio, 1.97; 95% confidence interval, 1.25-3.10, P = .004) had worse DFS.

Conclusions

Lobectomy should be considered over sublobar resection for stage IA NSCLC ≤2 cm in the presence of multiple high-risk features.
目的:探讨具有术前高危特征的IA期非小细胞肺癌(NSCLC)的叶下切除术与叶下切除术的无病生存率(DFS)。方法:从前瞻性数据库中提取数据,识别临床T1a-T1bN0M0 NSCLC(≤2 cm)行肺叶切除术或叶下切除术(楔形切除术或节段切除术)的患者。使用1:1倾向匹配来平衡FEV1≥60%的数据集和高风险特征:cT1b与cT1a, PET上原发肿瘤的SUV, CT上实性与次实性肿瘤质地,微乳头状(MIP)/实性组织学。主要终点为DFS。结果:825例患者符合纳入标准:52% (N=426)的患者行肺叶切除术,48% (N=399)的患者行肺叶下切除术(45%节段切除术,55%楔形切除术)。结论:对于≤2cm的IA期NSCLC,在存在多种高危特征的情况下,应考虑行肺叶切除术,而非叶下切除术。
{"title":"Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non−small cell lung cancer","authors":"Raul Caso MD, MSCI ,&nbsp;Nanruoyi Zhou MD ,&nbsp;Matthew Skovgard MD ,&nbsp;Nicolas Toumbacaris MSPH ,&nbsp;Kay See Tan PhD ,&nbsp;Prasad S. Adusumilli MD ,&nbsp;Manjit S. Bains MD ,&nbsp;Matthew J. Bott MD ,&nbsp;Robert J. Downey MD ,&nbsp;James Huang MD ,&nbsp;James M. Isbell MD, MSCI ,&nbsp;Daniela Molena MD ,&nbsp;Bernard J. Park MD ,&nbsp;Gaetano Rocco MD ,&nbsp;Valerie W. Rusch MD ,&nbsp;Smita Sihag MD ,&nbsp;David R. Jones MD ,&nbsp;Katherine D. Gray MD","doi":"10.1016/j.jtcvs.2025.08.024","DOIUrl":"10.1016/j.jtcvs.2025.08.024","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate disease-free survival (DFS) of sublobar resection versus lobectomy for stage IA non−small cell lung cancer (NSCLC) with preoperative high-risk features.</div></div><div><h3>Methods</h3><div>Data were abstracted from a prospective database to identify patients with clinical T1a-T1bN0M0 NSCLC (≤2 cm) who underwent lobectomy or sublobar resection (wedge resection or segmentectomy). 1:1 propensity matching was used to balance the dataset for forced expiratory volume in 1 second ≥60% and high-risk features: cT1b versus cT1a, standard uptake value of the primary tumor on positron emission tomography, solid versus subsolid tumor texture on computed tomography, and micropapillary/solid histology. The primary outcome was DFS.</div></div><div><h3>Results</h3><div>In total, 825 patients met inclusion criteria: 52% (n = 426) patients underwent lobectomy and 48% (n = 399) of patients underwent sublobar resection (45% segmentectomy, 55% wedge resection). Lobectomy was associated with more preoperative high-risk features: cT1b (<em>P</em> &lt; .001), greater standard uptake value (<em>P</em> &lt; .001), solid tumor texture on computed tomography (<em>P</em> &lt; .001), and micropapillary/solid histology (<em>P</em> &lt; .001). In total, 660 patients were included in the matched analysis with all high-risk features balanced. Nodal upstaging (N1) was greater in patients who underwent lobectomy (9.1% vs 3.4%, <em>P</em> = .004). Five-year DFS (85% vs 74%, <em>P</em> = .12) was equivalent in the matched cohort. Lobectomy was protective for recurrence in the presence of 2 or greater high-risk features: sublobar resection patients with 2 high-risk features (hazard ratio, 1.77; 95% confidence interval, 1.13-2.76, <em>P</em> = .012) or 3-4 high-risk features (hazard ratio, 1.97; 95% confidence interval, 1.25-3.10, <em>P</em> = .004) had worse DFS.</div></div><div><h3>Conclusions</h3><div>Lobectomy should be considered over sublobar resection for stage IA NSCLC ≤2 cm in the presence of multiple high-risk features.</div></div>","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Pages 510-518.e2"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144976785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “2025 American Association for Thoracic Surgery Congenital Cardiac Surgery Working Group—Expert consensus document on the management of patients with pulmonary atresia with intact ventricular septum” (Journal of Thoracic and Cardiovascular Surgery, 2025;170(2):336–352) “2025年美国胸外科协会先天性心脏外科工作组关于完全性室间隔肺闭锁患者处理的专家共识文件”的勘误表(胸外科与心血管外科杂志,2025;170(2):336-352)。
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/j.jtcvs.2025.09.006
James Jaggers MD , David Winlaw MD, FRACS , Stephanie Fuller MD , Neeta Sethi MD , Lazaros Kochilas MD , Iki Adachi MD , Matthew Stone MD , Lorna Browne MD , Nee Khoo MD , Eduardo da Cruz MD , Christopher Petit MD , Damien LaPar MD, MSc , Lydia Wright MD , Karen Stout MD , Mary Donofrio MD, FAAP, FACC, FASE , James St Louis MD, FACC, FACS
{"title":"Corrigendum to “2025 American Association for Thoracic Surgery Congenital Cardiac Surgery Working Group—Expert consensus document on the management of patients with pulmonary atresia with intact ventricular septum” (Journal of Thoracic and Cardiovascular Surgery, 2025;170(2):336–352)","authors":"James Jaggers MD ,&nbsp;David Winlaw MD, FRACS ,&nbsp;Stephanie Fuller MD ,&nbsp;Neeta Sethi MD ,&nbsp;Lazaros Kochilas MD ,&nbsp;Iki Adachi MD ,&nbsp;Matthew Stone MD ,&nbsp;Lorna Browne MD ,&nbsp;Nee Khoo MD ,&nbsp;Eduardo da Cruz MD ,&nbsp;Christopher Petit MD ,&nbsp;Damien LaPar MD, MSc ,&nbsp;Lydia Wright MD ,&nbsp;Karen Stout MD ,&nbsp;Mary Donofrio MD, FAAP, FACC, FASE ,&nbsp;James St Louis MD, FACC, FACS","doi":"10.1016/j.jtcvs.2025.09.006","DOIUrl":"10.1016/j.jtcvs.2025.09.006","url":null,"abstract":"","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Page 348"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145372710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information for readers 读者资讯
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/S0022-5223(25)01080-3
{"title":"Information for readers","authors":"","doi":"10.1016/S0022-5223(25)01080-3","DOIUrl":"10.1016/S0022-5223(25)01080-3","url":null,"abstract":"","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Page 558"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146081877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refining preoperative diabetes assessment: Implications for acute myocardial infarction-coronary artery bypass grafting management and long-term outcomes 改进术前糖尿病评估:对急性心肌梗死-冠状动脉旁路移植术管理和长期结果的影响。
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/j.jtcvs.2025.02.017
Mengxia Qi MM , Xiangying Yang MM
{"title":"Refining preoperative diabetes assessment: Implications for acute myocardial infarction-coronary artery bypass grafting management and long-term outcomes","authors":"Mengxia Qi MM ,&nbsp;Xiangying Yang MM","doi":"10.1016/j.jtcvs.2025.02.017","DOIUrl":"10.1016/j.jtcvs.2025.02.017","url":null,"abstract":"","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Pages e41-e42"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tissue perfusion pressure: A novel hemodynamic measure to assess risk of acute kidney injury after cardiac surgery 组织灌注压:评估心脏手术后急性肾损伤风险的一种新的血流动力学指标。
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/j.jtcvs.2025.07.009
Travis J. Miles MD , Michael T. Guinn MD , Xin Tan BS , Hao Qi BS , Vicente Orozco-Sevilla MD , Marc R. Moon MD , Joseph S. Coselli MD , Todd K. Rosengart MD , Meng Li PhD , Subhasis Chatterjee MD , Ravi K. Ghanta MD

Background

Optimal hemodynamic targets for preventing acute kidney injury (AKI) have remained elusive. We hypothesized that lower tissue perfusion pressure (TPP), a novel perfusion index representing the difference between mean arterial pressure and the critical closing pressure, is predictive of AKI after cardiac surgery.

Methods

Individual patient TPP waveforms were constructed from continuous hemodynamic data in 1224 patients after cardiac surgery. The relationship of TPP and AKI was determined and stratified by vasoactive inotrope score. Logistic regression was performed to identify the optimal TPP threshold for predicting AKI. Unsupervised machine learning was used to explore different hemodynamic phenotypes and their association with AKI.

Results

AKI occurred in 17.6% of patients and was associated with higher rates of mortality (15.8% vs 2.0%; P < .001) and major morbidity (45.1% vs 14.2%; P < .001) and significantly lower average TPP (37.6 mm Hg [33.7-41.0 mm Hg] vs 39.0 mm Hg [34.6-42.6 mm Hg], P < .001). A threshold TPP <38 mm Hg effectively stratified patients by AKI risk (odds ratio, 1.75; 95% CI, 1.30-2.35). For patients requiring vasoactive medications, average TPP <38 mm Hg indicated higher risk of AKI independent of average mean arterial pressure (adjusted odds ratio, 1.69; 95% CI, 1.17-2.45). K-means clustering identified a high-risk phenotype with lower average TPP (35.6 mm Hg [30.9-39.8 mm Hg] vs 40.4 mm Hg [35.9-44.5 mm Hg]; P < .001), higher average vasoactive inotrope score (2.8 [0.3-6.8] vs 0.5 [0.0-2.5], P < .001), and greater incidence of AKI (29.8% vs 10.1%; P < .001).

Conclusions

Lower TPP is associated with greater risk of AKI after cardiac surgery. TPP could serve as an adjunct to traditional hemodynamic measures to guide hemodynamic management, especially in patients with higher vasopressor requirements.
背景:预防急性肾损伤(AKI)的最佳血流动力学目标仍然难以捉摸。我们假设较低的组织灌注压(TPP)是一种代表平均动脉压(MAP)与临界闭合压之差的新灌注指标,可以预测心脏手术后AKI的发生。方法:利用1224例心脏手术后患者的连续血流动力学数据构建个体TPP波形。通过血管活性肌力评分(vasoactive inotrope score, VIS)确定TPP与AKI的关系并进行分层。采用Logistic回归来确定预测AKI的最佳TPP阈值。使用无监督机器学习来探索不同的血液动力学表型及其与AKI的关系。结果:17.6%的患者发生AKI,并与较高的死亡率相关(15.8% vs 2.0%)。结论:较低的TPP与心脏手术后AKI的高风险相关。TPP可以作为传统血液动力学措施的辅助手段,指导血液动力学管理,特别是在血管加压药物需求较高的患者中。
{"title":"Tissue perfusion pressure: A novel hemodynamic measure to assess risk of acute kidney injury after cardiac surgery","authors":"Travis J. Miles MD ,&nbsp;Michael T. Guinn MD ,&nbsp;Xin Tan BS ,&nbsp;Hao Qi BS ,&nbsp;Vicente Orozco-Sevilla MD ,&nbsp;Marc R. Moon MD ,&nbsp;Joseph S. Coselli MD ,&nbsp;Todd K. Rosengart MD ,&nbsp;Meng Li PhD ,&nbsp;Subhasis Chatterjee MD ,&nbsp;Ravi K. Ghanta MD","doi":"10.1016/j.jtcvs.2025.07.009","DOIUrl":"10.1016/j.jtcvs.2025.07.009","url":null,"abstract":"<div><h3>Background</h3><div>Optimal hemodynamic targets for preventing acute kidney injury (AKI) have remained elusive. We hypothesized that lower tissue perfusion pressure (TPP), a novel perfusion index representing the difference between mean arterial pressure and the critical closing pressure, is predictive of AKI after cardiac surgery.</div></div><div><h3>Methods</h3><div>Individual patient TPP waveforms were constructed from continuous hemodynamic data in 1224 patients after cardiac surgery. The relationship of TPP and AKI was determined and stratified by vasoactive inotrope score. Logistic regression was performed to identify the optimal TPP threshold for predicting AKI. Unsupervised machine learning was used to explore different hemodynamic phenotypes and their association with AKI.</div></div><div><h3>Results</h3><div>AKI occurred in 17.6% of patients and was associated with higher rates of mortality (15.8% vs 2.0%; <em>P</em> &lt; .001) and major morbidity (45.1% vs 14.2%; <em>P</em> &lt; .001) and significantly lower average TPP (37.6 mm Hg [33.7-41.0 mm Hg] vs 39.0 mm Hg [34.6-42.6 mm Hg], <em>P</em> &lt; .001). A threshold TPP &lt;38 mm Hg effectively stratified patients by AKI risk (odds ratio, 1.75; 95% CI, 1.30-2.35). For patients requiring vasoactive medications, average TPP &lt;38 mm Hg indicated higher risk of AKI independent of average mean arterial pressure (adjusted odds ratio, 1.69; 95% CI, 1.17-2.45). <em>K</em>-means clustering identified a high-risk phenotype with lower average TPP (35.6 mm Hg [30.9-39.8 mm Hg] vs 40.4 mm Hg [35.9-44.5 mm Hg]; <em>P</em> &lt; .001), higher average vasoactive inotrope score (2.8 [0.3-6.8] vs 0.5 [0.0-2.5], <em>P</em> &lt; .001), and greater incidence of AKI (29.8% vs 10.1%; <em>P</em> &lt; .001).</div></div><div><h3>Conclusions</h3><div>Lower TPP is associated with greater risk of AKI after cardiac surgery. TPP could serve as an adjunct to traditional hemodynamic measures to guide hemodynamic management, especially in patients with higher vasopressor requirements.</div></div>","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Pages 455-462.e3"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144668835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet responsiveness to aspirin in pediatric patients undergoing cardiac surgery: A prospective cohort study 儿童心脏手术患者血小板对阿司匹林的反应性——一项前瞻性队列研究。
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/j.jtcvs.2025.09.013
Supreet P. Marathe FRACS , Stacey Van Dyk BN , Sally Campbell FRACP , Kim S. Betts PhD , Pasquale Barbaro FRACP , Siddharth Amboli MCh , Benjamin Anderson FRACP , Adrian Mattke FCICM , Prem Venugopal FRACS , Nelson Alphonso FRACS
<div><h3>Background</h3><div>Aspirin at 3 to 5 mg/kg is the cornerstone of thromboprophylaxis in pediatric cardiac surgery. The reported prevalence of aspirin unresponsiveness is 1% to 35% in adults and 10% to 15% in children. The present study aimed to (1) describe the prevalence of aspirin responsiveness in the pediatric cardiac surgical population using light transmission aggregometry (LTA), the gold standard; (2) evaluate the dose-dependent response to aspirin; (3) compare LTA with point-of-care thromboelastography with platelet mapping (TEG-PM); and (4) describe adverse events and report a risk factor analysis.</div></div><div><h3>Methods</h3><div>This prospective cohort study (Clinical Trials Registry ACTRN12618001879257) was conducted from 2022 to 2024 in a quaternary children's hospital and included patients age 0 to 18 years who required aspirin prophylaxis after cardiac surgery. Patients who were allergic to aspirin or received other anticoagulants, such as warfarin, were excluded. Aspirin responsiveness was tested after at least 3 days of a standard aspirin dose of 5 mg/kg or 150 mg (whichever was less). LTA showing ≥20% platelet aggregation stimulated by arachidonic acid or ≥70% platelet aggregation to adenosine diphosphate denoted aspirin unresponsiveness. To evaluate TEG-PM compared to the gold standard (LTA), TEG-PM showing ≥50% platelet aggregation denoted aspirin unresponsiveness. The dose was increased to 10 mg/kg in these patients, and aspirin responsiveness was reevaluated. Those patients still not responding were labeled “aspirin-resistant.”</div></div><div><h3>Results</h3><div>The 133 eligible patients included 77 males (58%), 49 with a single ventricle (37%), and 119 who underwent surgery using cardiopulmonary bypass (89%). The most common indications for aspirin were shunts/Fontan in single ventricle patients (n = 44; 33%) and valve repair/replacement (n = 25; 19%). The median patient age was 1.9 years (interquartile range [IQR], 0.13-12 years), and the median weight was 15.1 kg (IQR, 4.2-44.1 kg). Twenty-four patients (18%) did not respond to the standard aspirin dose, and the dose was increased in 23 patients (17%). Twenty patients (15%) were tested a second time; 13 (10%) responded to the increased aspirin dose (10 mg/kg). Seven patients (5%) were aspirin-resistant. There was no correlation between the results of aspirin responsiveness tested using LTA and TEG-PM (<em>P</em> = .167). There were no identifiable risk factors for aspirin unresponsiveness.</div></div><div><h3>Conclusions</h3><div>Almost 20% of pediatric cardiac surgical patients do not respond to a standard 5 mg/kg aspirin dose. Most non-responders have a dose-dependent response to aspirin. Only 5% of patients are genuinely aspirin-resistant (as defined by LTA). TEG-PM does not correlate with the gold standard LTA test to determine aspirin responsiveness. Testing for aspirin responsiveness should be considered in patients undergoing pediatric cardiac surger
目的:3-5 mg/kg的阿司匹林是儿童心脏外科血栓预防的基石。据报道,阿司匹林无反应率在成人中为1-35%,在儿童中为10-15%。本研究的目的是:(1)使用光透射聚集法(LTA;金标准)评估儿童心脏手术人群中阿司匹林反应性的患病率(2)评估阿司匹林的剂量依赖性反应(3)比较LTA与即时血栓弹性成像血小板制图(TEG-PM)(4)不良事件和危险因素分析。方法:前瞻性队列研究(临床试验注册ACTRN12618001879257),于2022年至2024年在一家第四儿童医院进行,年龄在0至18岁之间,心脏手术后需要阿司匹林预防的患者。对阿司匹林过敏或接受华法林等其他抗凝剂的患者被排除在外。服用标准剂量阿司匹林(5mg /kg或150mg)至少3天后测试阿司匹林反应性(以较低者为准)。LTA显示花生四烯酸刺激血小板聚集≥20% /血小板聚集≥70%为阿司匹林无反应性。将TEG-PM与金标准(LTA)进行比较,TEG-PM显示血小板聚集≥50%表示阿司匹林无反应性。这些患者的剂量增加到10mg /kg,并重新评估阿司匹林的反应性。那些仍然没有反应的患者被标记为“阿司匹林耐药”。结果:133例符合条件的患者[男性77例(58%),单心室49例(37%),体外循环手术119例(89%)]。阿司匹林最常见的适应症是单心室患者分流/Fontan (n=44, 33%)和瓣膜修复/置换术(n=25, 19%)。中位年龄为1.9岁(IQR为0.13-12),中位体重为15.1 kg (IQR为4.2-44.1)。24例(18%)患者对标准剂量阿司匹林无反应。23例(17%)患者剂量增加。20例(15%)患者进行了第二次检测。13例(10%)患者对增加阿司匹林剂量(10mg /kg)有反应。7例患者(5%)对阿司匹林耐药。LTA与TEG-PM阿司匹林反应性检测结果无相关性(p=0.167)。阿司匹林无反应性没有可识别的危险因素。结论:1/5的儿科心脏手术患者对标准剂量5mg /kg阿司匹林无反应。大多数无反应者对阿司匹林有剂量依赖性反应。只有5%的患者是真正的阿司匹林耐药(根据LTA的定义)。TEG-PM与测定阿司匹林反应性的金标准LTA试验无关。在接受儿科心脏手术的有临床显著血栓形成风险的患者中,应考虑阿司匹林反应性检测。然而,需要与临床结果相关的进一步证据来确定阿司匹林反应性检测的效用。
{"title":"Platelet responsiveness to aspirin in pediatric patients undergoing cardiac surgery: A prospective cohort study","authors":"Supreet P. Marathe FRACS ,&nbsp;Stacey Van Dyk BN ,&nbsp;Sally Campbell FRACP ,&nbsp;Kim S. Betts PhD ,&nbsp;Pasquale Barbaro FRACP ,&nbsp;Siddharth Amboli MCh ,&nbsp;Benjamin Anderson FRACP ,&nbsp;Adrian Mattke FCICM ,&nbsp;Prem Venugopal FRACS ,&nbsp;Nelson Alphonso FRACS","doi":"10.1016/j.jtcvs.2025.09.013","DOIUrl":"10.1016/j.jtcvs.2025.09.013","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Aspirin at 3 to 5 mg/kg is the cornerstone of thromboprophylaxis in pediatric cardiac surgery. The reported prevalence of aspirin unresponsiveness is 1% to 35% in adults and 10% to 15% in children. The present study aimed to (1) describe the prevalence of aspirin responsiveness in the pediatric cardiac surgical population using light transmission aggregometry (LTA), the gold standard; (2) evaluate the dose-dependent response to aspirin; (3) compare LTA with point-of-care thromboelastography with platelet mapping (TEG-PM); and (4) describe adverse events and report a risk factor analysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;This prospective cohort study (Clinical Trials Registry ACTRN12618001879257) was conducted from 2022 to 2024 in a quaternary children's hospital and included patients age 0 to 18 years who required aspirin prophylaxis after cardiac surgery. Patients who were allergic to aspirin or received other anticoagulants, such as warfarin, were excluded. Aspirin responsiveness was tested after at least 3 days of a standard aspirin dose of 5 mg/kg or 150 mg (whichever was less). LTA showing ≥20% platelet aggregation stimulated by arachidonic acid or ≥70% platelet aggregation to adenosine diphosphate denoted aspirin unresponsiveness. To evaluate TEG-PM compared to the gold standard (LTA), TEG-PM showing ≥50% platelet aggregation denoted aspirin unresponsiveness. The dose was increased to 10 mg/kg in these patients, and aspirin responsiveness was reevaluated. Those patients still not responding were labeled “aspirin-resistant.”&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The 133 eligible patients included 77 males (58%), 49 with a single ventricle (37%), and 119 who underwent surgery using cardiopulmonary bypass (89%). The most common indications for aspirin were shunts/Fontan in single ventricle patients (n = 44; 33%) and valve repair/replacement (n = 25; 19%). The median patient age was 1.9 years (interquartile range [IQR], 0.13-12 years), and the median weight was 15.1 kg (IQR, 4.2-44.1 kg). Twenty-four patients (18%) did not respond to the standard aspirin dose, and the dose was increased in 23 patients (17%). Twenty patients (15%) were tested a second time; 13 (10%) responded to the increased aspirin dose (10 mg/kg). Seven patients (5%) were aspirin-resistant. There was no correlation between the results of aspirin responsiveness tested using LTA and TEG-PM (&lt;em&gt;P&lt;/em&gt; = .167). There were no identifiable risk factors for aspirin unresponsiveness.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Almost 20% of pediatric cardiac surgical patients do not respond to a standard 5 mg/kg aspirin dose. Most non-responders have a dose-dependent response to aspirin. Only 5% of patients are genuinely aspirin-resistant (as defined by LTA). TEG-PM does not correlate with the gold standard LTA test to determine aspirin responsiveness. Testing for aspirin responsiveness should be considered in patients undergoing pediatric cardiac surger","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Pages 338-347.e1"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute type A dissection with iliofemoral or renal malperfusion: Is frozen elephant trunk necessary? 急性A型解剖伴髂股或肾灌注不良:有必要冷冻象鼻吗?
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/j.jtcvs.2025.09.014
Alexander P. Nissen MD , Ross Michael Reul MD , Muhammad Naeem MD , Jonathan R. Zurcher MD , Woodrow J. Farrington MD , William Brent Keeling MD , Bradley G. Leshnower MD

Background

Frozen elephant trunk (FET) is being increasingly used for acute type A aortic dissection (ATAAD) with distal malperfusion. The efficacy of adding a stent graft remains unclear, however. This study investigated the efficacy of adding FET to conventional arch repair when treating ATAAD with iliofemoral or renal malperfusion.

Methods

A review of the Emory Aortic Database identified 969 patients with acute DeBakey 1 dissection from 2004 to February 2025. One hundred fifty-three patients with iliofemoral and/or renal malperfusion underwent emergent central aortic repair alone (conventional group; n = 102) or central repair plus FET (FET group; n = 51). Univariate statistics were used to compare the 2 groups. Multivariable logistic regression was used to examine factors associated with postoperative limb revascularization and new renal failure. Selection bias was addressed through inverse-probability treatment weighting adjustment.

Results

Age and preoperative comorbidities were equivalent in the 2 groups. Limb ischemia requiring revascularization (17.6% for conventional vs 15.7% for FET; P = .856), or new dialysis (21.6% for conventional vs 17.6% for FET; P = .547) also was similar between the groups. Multivariable regression did not identify FET as independently associated with a reduced need for limb revascularization in iliofemoral malperfusion patients (odds ratio [OR], 1.334; 95% confidence interval [CI], 0.434-4.098; P = .614) or with avoiding dialysis in renal malperfusion patients (OR, 1.166; 95% CI, 0.252-5.382; P = .844). Mid-term survival (71.1% for conventional 71.1% vs 75.5% for FET; log-rank P = .753) and distal reintervention-free survival (64.9% for conventional vs 69.4% for FET; log-rank P = .902) were equivalent.

Conclusions

The addition of FET to conventional repair did not impact limb revascularization, new dialysis, or mid-term reintervention or improve mid-term survival in ATAAD with iliofemoral or renal malperfusion.
目的:冷冻象鼻(FET)越来越多地用于急性A型主动脉夹层(ATAAD)远端灌注不良。然而,增加支架移植的效果尚不清楚。本研究探讨了在常规弓修复中加入场效应晶体管治疗伴髂股或肾灌注不良的ATAAD的疗效。方法:回顾Emory主动脉数据库,从2004年至2025年2月,确定了969例急性DeBakey 1型夹层患者。153例髂股和/或肾脏灌注不良患者接受了紧急中央主动脉修复术(常规,n=102)或中央修复+ FET (FET, n= 51)。采用单变量统计进行组间比较。采用多变量logistic回归分析术后肢体血运重建和新发肾功能衰竭的相关因素。利用逆概率处理加权(IPTW)调整来解决选择偏差。结果:两组患者的年龄和术前合并症相当。肢体缺血需要血供重建术(常规17.6% vs FET 15.7% p=0.856),或新透析(常规21.6% vs FET 17.6%, p=0.547)组间相等。多变量回归未发现FET与髂股灌注不良患者肢体血运重建需求减少独立相关(OR为1.334 [0.434-4.098],p=0.614),也未发现肾灌注不良患者避免透析(OR为1.166 [0.52 -5.382],p=0.844)。中期生存率(常规71.1% vs. FET 75.5%, log-rank p=0.753)和远端无再干预生存率(常规64.9% vs. FET 69.4%, log-rank p=0.902)相当。结论:在常规修复的基础上加入FET对合并髂股或肾灌注不良的A型夹层患者的肢体血运重建、新透析、中期再干预或改善中期生存无影响。
{"title":"Acute type A dissection with iliofemoral or renal malperfusion: Is frozen elephant trunk necessary?","authors":"Alexander P. Nissen MD ,&nbsp;Ross Michael Reul MD ,&nbsp;Muhammad Naeem MD ,&nbsp;Jonathan R. Zurcher MD ,&nbsp;Woodrow J. Farrington MD ,&nbsp;William Brent Keeling MD ,&nbsp;Bradley G. Leshnower MD","doi":"10.1016/j.jtcvs.2025.09.014","DOIUrl":"10.1016/j.jtcvs.2025.09.014","url":null,"abstract":"<div><h3>Background</h3><div>Frozen elephant trunk (FET) is being increasingly used for acute type A aortic dissection (ATAAD) with distal malperfusion. The efficacy of adding a stent graft remains unclear, however. This study investigated the efficacy of adding FET to conventional arch repair when treating ATAAD with iliofemoral or renal malperfusion.</div></div><div><h3>Methods</h3><div>A review of the Emory Aortic Database identified 969 patients with acute DeBakey 1 dissection from 2004 to February 2025. One hundred fifty-three patients with iliofemoral and/or renal malperfusion underwent emergent central aortic repair alone (conventional group; n = 102) or central repair plus FET (FET group; n = 51). Univariate statistics were used to compare the 2 groups. Multivariable logistic regression was used to examine factors associated with postoperative limb revascularization and new renal failure. Selection bias was addressed through inverse-probability treatment weighting adjustment.</div></div><div><h3>Results</h3><div>Age and preoperative comorbidities were equivalent in the 2 groups. Limb ischemia requiring revascularization (17.6% for conventional vs 15.7% for FET; <em>P</em> = .856), or new dialysis (21.6% for conventional vs 17.6% for FET; <em>P</em> = .547) also was similar between the groups. Multivariable regression did not identify FET as independently associated with a reduced need for limb revascularization in iliofemoral malperfusion patients (odds ratio [OR], 1.334; 95% confidence interval [CI], 0.434-4.098; <em>P</em> = .614) or with avoiding dialysis in renal malperfusion patients (OR, 1.166; 95% CI, 0.252-5.382; <em>P</em> = .844). Mid-term survival (71.1% for conventional 71.1% vs 75.5% for FET; log-rank <em>P</em> = .753) and distal reintervention-free survival (64.9% for conventional vs 69.4% for FET; log-rank <em>P</em> = .902) were equivalent.</div></div><div><h3>Conclusions</h3><div>The addition of FET to conventional repair did not impact limb revascularization, new dialysis, or mid-term reintervention or improve mid-term survival in ATAAD with iliofemoral or renal malperfusion.</div></div>","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Pages 366-373.e1"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between subclavian vein patency and health-related quality of life outcomes among patients with venous thoracic outlet syndrome 静脉胸廓出口综合征患者锁骨下静脉通畅与健康相关生活质量的关系
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/j.jtcvs.2025.08.035
Michaela E. Corvi BA , Nikhil Panda MD, MPH , Beverly J. Fu BA, MA , Jacob C. Hurd BS , Margaret E. Yang BS , Jacob N. Anderson BS , Sangkavi Kuhan BS , Chi-Fu Jeffery Yang MD , Dean M. Donahue MD

Objective

The study objective was to evaluate the association between subclavian vein patency and health-related quality of life after supraclavicular thoracic outlet decompression among patients with venous thoracic outlet syndrome.

Methods

Patients who underwent supraclavicular thoracic outlet decompression (ie, first thoracic rib resection, scalenectomy, and subclavian venolysis) were identified from a prospectively maintained database. Demography, perioperative venography, and catheter-directed interventions were recorded. The primary end points were subclavian vein patency and health-related quality of life after decompression. The association between subclavian vein patency and health-related quality of life was evaluated in unadjusted and logistic regression analyses.

Results

Among 1032 patients with thoracic outlet syndrome who underwent surgery (2007-2021), 275 patients presented with venous thoracic outlet syndrome. A total of 225 patients (81.8%) underwent preoperative venography; 221 patients (98.2%) had completely or partially stenosed subclavian veins. Preoperative catheter-based interventions were performed in 166 patients (60.4%); stenosis remained in 130 patients (78.3%). Postoperatively, 216 patients (78.5%) underwent routine venography; improvement in stenosis was observed in 54 patients (25.0%). Additional catheter-based interventions were performed in 155 patients (56.4%) with improvement in stenosis observed in 131 patients (84.5%). At a median follow-up of 279 days (interquartile range, 95-674), 94.0% of patients reported improvement in health-related quality of life. Improvement in subclavian vein patency was associated with improved health-related quality of life (adjusted odds ratio, 2.19 [95% CI, 1.12-4.28], P = .021).

Conclusions

Subclavian vein patency is associated with improved health-related quality of life among patients with venous thoracic outlet syndrome. Effective venolysis during thoracic outlet decompression with perioperative catheter-directed intervention contributes most significantly to vein patency.
目的:评价静脉胸廓出口综合征患者锁骨上胸廓出口减压术后锁骨下静脉通畅与健康相关生活质量的关系。方法:从前瞻性维护的数据库中确定接受锁骨上胸廓出口减压术(即第一胸椎肋骨切除术、斜角切除术和锁骨下静脉溶解术)的患者。记录人口统计学、围手术期静脉造影和导管定向干预。主要终点是锁骨下静脉通畅和减压后健康相关生活质量。锁骨下静脉通畅与健康相关生活质量之间的关系通过未调整和逻辑回归分析进行评估。结果:在1032例接受手术的TOS患者中(2007-2021),275例患者出现静脉胸廓出口综合征。225例(81.8%)患者行术前静脉造影;锁骨下静脉完全或部分狭窄221例(98.2%)。166例患者(60.4%)接受了术前导管干预;130例(78.3%)患者仍存在狭窄。术后常规静脉造影216例(78.5%);54例(25.0%)狭窄改善。155例(56.4%)患者进行了额外的导管干预,131例(84.5%)患者的狭窄得到改善。在中位随访279天[IQR 95,674]时,94.0%的患者报告健康相关生活质量有所改善。锁骨下静脉通畅的改善与健康相关生活质量的改善相关(校正优势比2.19 [95%CI 1.12-4.28], p=0.021)。结论:锁骨下静脉通畅与静脉胸廓出口综合征患者健康相关生活质量的改善有关。围手术期导管介入胸廓出口减压术中有效的静脉溶解有助于静脉通畅。
{"title":"Association between subclavian vein patency and health-related quality of life outcomes among patients with venous thoracic outlet syndrome","authors":"Michaela E. Corvi BA ,&nbsp;Nikhil Panda MD, MPH ,&nbsp;Beverly J. Fu BA, MA ,&nbsp;Jacob C. Hurd BS ,&nbsp;Margaret E. Yang BS ,&nbsp;Jacob N. Anderson BS ,&nbsp;Sangkavi Kuhan BS ,&nbsp;Chi-Fu Jeffery Yang MD ,&nbsp;Dean M. Donahue MD","doi":"10.1016/j.jtcvs.2025.08.035","DOIUrl":"10.1016/j.jtcvs.2025.08.035","url":null,"abstract":"<div><h3>Objective</h3><div>The study objective was to evaluate the association between subclavian vein patency and health-related quality of life after supraclavicular thoracic outlet decompression among patients with venous thoracic outlet syndrome.</div></div><div><h3>Methods</h3><div>Patients who underwent supraclavicular thoracic outlet decompression (ie, first thoracic rib resection, scalenectomy, and subclavian venolysis) were identified from a prospectively maintained database. Demography, perioperative venography, and catheter-directed interventions were recorded. The primary end points were subclavian vein patency and health-related quality of life after decompression. The association between subclavian vein patency and health-related quality of life was evaluated in unadjusted and logistic regression analyses.</div></div><div><h3>Results</h3><div>Among 1032 patients with thoracic outlet syndrome who underwent surgery (2007-2021), 275 patients presented with venous thoracic outlet syndrome. A total of 225 patients (81.8%) underwent preoperative venography; 221 patients (98.2%) had completely or partially stenosed subclavian veins. Preoperative catheter-based interventions were performed in 166 patients (60.4%); stenosis remained in 130 patients (78.3%). Postoperatively, 216 patients (78.5%) underwent routine venography; improvement in stenosis was observed in 54 patients (25.0%). Additional catheter-based interventions were performed in 155 patients (56.4%) with improvement in stenosis observed in 131 patients (84.5%). At a median follow-up of 279 days (interquartile range, 95-674), 94.0% of patients reported improvement in health-related quality of life. Improvement in subclavian vein patency was associated with improved health-related quality of life (adjusted odds ratio, 2.19 [95% CI, 1.12-4.28], <em>P</em> = .021).</div></div><div><h3>Conclusions</h3><div>Subclavian vein patency is associated with improved health-related quality of life among patients with venous thoracic outlet syndrome. Effective venolysis during thoracic outlet decompression with perioperative catheter-directed intervention contributes most significantly to vein patency.</div></div>","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Pages 551-557.e1"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145006762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term survival and operative outcomes of the Bentall procedure for aortic root aneurysm, aortic dissection, and endocarditis 本特尔手术治疗主动脉根动脉瘤、主动脉夹层和心内膜炎的长期生存率和手术结果。
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/j.jtcvs.2025.09.018
Christopher Lau MD, Alexander Gregg MD, Eilon Ram MD, Charles Mack MD, Katherine Krieger BS, Mohamed Rahouma MD, Ivancarmine Gambardella MD, Giovanni Soletti Jr. MD, Mario Gaudino MD, Leonard N. Girardi MD

Objective

To assess outcomes after aortic root replacement with Bentall procedure for aortic aneurysm, dissection, and endocarditis.

Methods

We identified consecutive patients undergoing Bentall procedures from 1997 to 2023, with stratification based on the primary diagnosis. Operative outcomes and long-term survival were compared.

Results

Of 1493 patients, 1378 (92.3%) underwent surgery for aneurysms, 75 (5%) for dissections, and 40 (2.7%) for endocarditis. The aneurysm group was older (61 years [range, 50-70 years] vs 57 years [range, 47-66.5 years] vs 56 years [range, 49-64 years]; P = .024). Patients with dissection or endocarditis had more preoperative myocardial infarctions (7.4% vs 12% vs 17.5%; P = .026), cerebrovascular accidents (9.6% vs 18.7% vs 45%; P < .001), renal dysfunction (8.3% vs 22.7% vs 45%; P < .001), shock (0.1% vs 10.7% vs 15%; P < .001), and ruptures (0.4% vs 10.7% vs 10%; P < .001). Regarding outcomes, acute renal failure (0.6% vs 1.3% vs 7.5%; P < .001) and operative mortality (0.4% vs 1.3% vs 7.5%; P = .001) were higher for endocarditis. Reexploration for bleeding was highest for dissections (4.1% vs 12% vs 2.5%; P = .004). Ten-year survival was similar between groups (71.8% vs 67% vs 83.7%; P = .94), with mean follow-up 68.2 ± 2.08 months. Multivariable analysis found age (hazard ratio [HR], 1.04; 95% CI, 1.03-1.05; P < .001), chronic obstructive pulmonary disease (HR, 2.12; 95% CI, 1.44-3.11; P < .001), renal dysfunction (HR, 1.97; 95% CI, 1.4-2.78; P < .001), and ejection fraction (HR, 0.97; 95% CI, 0.95-0.98; P < .001) were associated with late mortality but primary diagnosis was not.

Conclusions

The Bentall procedure can be performed with low operative risk for aneurysms and selected dissections. Endocarditis is associated with higher but acceptable operative mortality. Excellent long-term survival can be expected after surviving initial operative risk.
目的:评价本特尔主动脉根置换术治疗主动脉瘤、夹层和心内膜炎的疗效。方法:我们选取了1997-2023年间连续接受本特尔治疗的患者,根据初步诊断进行分层。比较两组患者的手术效果和长期生存率。结果:1493例患者中,动脉瘤手术1378例(92.3%),夹层手术75例(5%),心内膜炎手术40例(2.7%)。动脉瘤组年龄较大(61例[50,70]vs 57例[47,66.5]vs 56例[49,64];p=0.024)。夹层或心内膜炎患者术前心肌梗死发生率(7.4% vs 12% vs 17.5%; p=0.026)、脑血管意外发生率(9.6% vs 18.7% vs 45%)更高。结论:本特尔手术对动脉瘤和部分夹层的手术风险较低。心内膜炎与较高但可接受的手术死亡率相关。在克服了最初的手术风险后,可以预期良好的长期生存。
{"title":"Long-term survival and operative outcomes of the Bentall procedure for aortic root aneurysm, aortic dissection, and endocarditis","authors":"Christopher Lau MD,&nbsp;Alexander Gregg MD,&nbsp;Eilon Ram MD,&nbsp;Charles Mack MD,&nbsp;Katherine Krieger BS,&nbsp;Mohamed Rahouma MD,&nbsp;Ivancarmine Gambardella MD,&nbsp;Giovanni Soletti Jr. MD,&nbsp;Mario Gaudino MD,&nbsp;Leonard N. Girardi MD","doi":"10.1016/j.jtcvs.2025.09.018","DOIUrl":"10.1016/j.jtcvs.2025.09.018","url":null,"abstract":"<div><h3>Objective</h3><div>To assess outcomes after aortic root replacement with Bentall procedure for aortic aneurysm, dissection, and endocarditis.</div></div><div><h3>Methods</h3><div>We identified consecutive patients undergoing Bentall procedures from 1997 to 2023, with stratification based on the primary diagnosis. Operative outcomes and long-term survival were compared.</div></div><div><h3>Results</h3><div>Of 1493 patients, 1378 (92.3%) underwent surgery for aneurysms, 75 (5%) for dissections, and 40 (2.7%) for endocarditis. The aneurysm group was older (61 years [range, 50-70 years] vs 57 years [range, 47-66.5 years] vs 56 years [range, 49-64 years]; <em>P</em> = .024). Patients with dissection or endocarditis had more preoperative myocardial infarctions (7.4% vs 12% vs 17.5%; <em>P</em> = .026), cerebrovascular accidents (9.6% vs 18.7% vs 45%; <em>P</em> &lt; .001), renal dysfunction (8.3% vs 22.7% vs 45%; <em>P</em> &lt; .001), shock (0.1% vs 10.7% vs 15%; <em>P</em> &lt; .001), and ruptures (0.4% vs 10.7% vs 10%; <em>P</em> &lt; .001). Regarding outcomes, acute renal failure (0.6% vs 1.3% vs 7.5%; <em>P</em> &lt; .001) and operative mortality (0.4% vs 1.3% vs 7.5%; <em>P</em> = .001) were higher for endocarditis. Reexploration for bleeding was highest for dissections (4.1% vs 12% vs 2.5%; <em>P</em> = .004). Ten-year survival was similar between groups (71.8% vs 67% vs 83.7%; <em>P</em> = .94), with mean follow-up 68.2 ± 2.08 months. Multivariable analysis found age (hazard ratio [HR], 1.04; 95% CI, 1.03-1.05; <em>P</em> &lt; .001), chronic obstructive pulmonary disease (HR, 2.12; 95% CI, 1.44-3.11; <em>P</em> &lt; .001), renal dysfunction (HR, 1.97; 95% CI, 1.4-2.78; <em>P</em> &lt; .001), and ejection fraction (HR, 0.97; 95% CI, 0.95-0.98; <em>P</em> &lt; .001) were associated with late mortality but primary diagnosis was not.</div></div><div><h3>Conclusions</h3><div>The Bentall procedure can be performed with low operative risk for aneurysms and selected dissections. Endocarditis is associated with higher but acceptable operative mortality. Excellent long-term survival can be expected after surviving initial operative risk.</div></div>","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Pages 357-365.e2"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145115000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary: Symptomatic myocardial bridges—Bridging the unknown 评论:症状性心肌桥-桥接未知。
IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-01 DOI: 10.1016/j.jtcvs.2025.10.005
Anusha Jegatheeswaran MD, PhD, FRCSC , Ruchika Kamojjala BA
{"title":"Commentary: Symptomatic myocardial bridges—Bridging the unknown","authors":"Anusha Jegatheeswaran MD, PhD, FRCSC ,&nbsp;Ruchika Kamojjala BA","doi":"10.1016/j.jtcvs.2025.10.005","DOIUrl":"10.1016/j.jtcvs.2025.10.005","url":null,"abstract":"","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"171 2","pages":"Pages 427-428"},"PeriodicalIF":4.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Thoracic and Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1